Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,030

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

April 30, 2008

Study Completion Date

September 30, 2010

Conditions
Pancreatic Cancer
Interventions
DRUG

fluorouracil

Given IV

DRUG

gemcitabine hydrochloride

Given IV

DRUG

leucovorin calcium

Given IV

OTHER

clinical observation

No intervention

Trial Locations (27)

2031

Institute of Oncology at Prince of Wales Hospital, Randwick

5042

Flinders Medical Centre, Bedford Park

14021

Institute for Clinical and Experimental Medicine, Preha 4

33521

Tampere University Hospital, Tampere

37134

Policlinico Borgo Roma, Verona

75970

Hopital Tenon, Paris

T6G 1Z2

Cross Cancer Institute at University of Alberta, Edmonton

V1Y 5L3

British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna

V8R 6V5

British Columbia Cancer Agency - Vancouver Island Centre, Victoria

R3E 0V9

CancerCare Manitoba, Winnipeg

B3H 1V7

Nova Scotia Cancer Centre, Halifax

K7L 3N6

Cancer Research Institute at Queen's University, Kingston

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston

N6A 4L6

London Regional Cancer Program at London Health Sciences Centre, London

K1H 8L6

Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa

M4N 3M5

Edmond Odette Cancer Centre at Sunnybrook, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

M6R 1B5

St. Joseph's Health Centre - Toronto, Toronto

J4V 2H1

Hopital Charles Lemoyne, Greenfield Park

H2W 1S6

McGill Cancer Centre at McGill University, Montreal

D-69120

Universitaets-Kinderklinik Heidelberg, Heidelberg

G-15233

Agia Olga Hospital, Athens

h-9024

Petz Aladar County Hospital, Gydr

606-8507

Kyoto University Hospital, Kyoto

S-75185

Uppsala University Hospital, Uppsala

CH-3010

Inselspital Bern, Bern

L69 3GA

Royal Liverpool University Hospital, Liverpool

Sponsors
All Listed Sponsors
collaborator

NCIC Clinical Trials Group

NETWORK

collaborator

Australasian Gastro-Intestinal Trials Group

NETWORK

lead

Royal Liverpool University Hospital

OTHER_GOV